TIDMCLL

RNS Number : 6760V

Cello Health PLC

10 August 2020

10 August 2020

Cello Health plc

("Cello" or the "Company")

Relevant Securities in Issue

Further to the Exercise of Options announcement released by the Company earlier today and in accordance with Rule 2.9 of the Code, Cello confirms that, as at today's date, it has in issue 111,079,683 ordinary shares each with a nominal value of 10p. No ordinary shares are held in treasury.

The International Securities Identification Number (ISIN) of the Cello ordinary shares is GB00B0310763.

Enquires

 
 Cello Health                   020 7812 8460 
 Mark Scott, Chief Executive 
 Mark Bentley, Group Finance 
  Director 
 
 Cenkos Securities              020 7397 8900 
 Giles Balleny 
 Harry Hargreaves 
 
 Buchanan                       020 7466 5000 
 Mark Court 
 Jamie Hooper 
 Sophie Wills

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

TVRFLFLLTIIILII

(END) Dow Jones Newswires

August 10, 2020 07:12 ET (11:12 GMT)

Cello Health (LSE:CLL)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Cello Health Charts.
Cello Health (LSE:CLL)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Cello Health Charts.